BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Accenture
Farmers Insurance
Fish and Richardson
Boehringer Ingelheim
McKinsey
Deloitte
McKesson
Cipla
Citi

Generated: January 17, 2018

DrugPatentWatch Database Preview

ORUDIS Drug Profile

« Back to Dashboard

When do Orudis patents expire, and what generic alternatives are available?

Orudis is a drug marketed by Wyeth Ayerst and Wyeth Cons and is included in two NDAs.

The generic ingredient in ORUDIS is ketoprofen. There are twenty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.

US Patents and Regulatory Information for ORUDIS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-001 Jul 31, 1987 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Cons ORUDIS KT ketoprofen TABLET;ORAL 020429-001 Oct 6, 1995 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-002 Jan 9, 1986 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-003 Jan 9, 1986 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ORUDIS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-001 Jul 31, 1987 ➤ Subscribe ➤ Subscribe
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-002 Jan 9, 1986 ➤ Subscribe ➤ Subscribe
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-003 Jan 9, 1986 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Johnson and Johnson
Medtronic
Citi
Deloitte
Fuji
Argus Health
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot